Purchase of Pharmaceutical Agents for NIAID Clinical Trials
$777,180Y01FY2020AINIH
National Institute Of Allergy And Infectious Diseases
Investigators
Abstract
DLA Prime Vendor Program, is an intra-agency agreement that allows DAIT/ NIAID to purchase pharmaceutical agents with streamlined government pricing and negotiations.
View original record on NIH RePORTER →